http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab10238c04e003626dd3fedf7faea76f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hall |
| name | Per Hall |
| given-name | Per |
| organization-name | 7Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; and Institutionen för medicinsk epidemiologi och biostatistik, Karolinska institutet, Stockholm. Per.Hall@meb.ki.se Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden; Department of Oncology Sšdersjukhuset Stockholm Sweden Karolinska Institutet - Stockholm, Sweden. Department of Medical Epidemiology and Biostatics Karolinska Institutet Stockholm Sweden; Department of Oncology Södersjukhuset Stockholm Sweden Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Department of Medical Epidemiology and Biostatistics Karolinska Institute Solna Sweden; Department of Oncology Södersjukhuset Stockholm Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Södersjukhuset, Stockholm, Sweden From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; The University of Iowa, Iowa City, IA; Danish Cancer Society, Copenhagen, Denmark; Karolinska Institutet, Stockholm, Sweden; Cancer Registry of Norway, Oslo, Norway; Finnish Cancer Registry; and the Helsinki University Central Hospital, Helsinki, Finland. 11 Department of Medical Epidemiology and Biostatistics Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm 171 77 Sweden 2Department of Medical Epidemiology and Biostatistics; and From the Marshfield Clinic Weston Center, Weston, WI; Department of Molecular Medicine and Surgery, Karolinska University Hospital; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; and the Department of Community Medicine (Biostatistics), Kuwait University; Division of Endocrinology, Mubarak Al-Kabeer Teaching Hospital; and the Department of Medicine, Kuwait University, Kuwait. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden. Wei He, Fang Fang, Mikael Eriksson, Per Hall, Kamila Czene, Karolinska Institutet, Stockholm, Sweden; and Catherine Varnum, School of Medicine, University of Maryland, Baltimore, MD. Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom Department of Oncology, Södersjukhuset, 11883 Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17165 Stockholm, Sweden All authors: Karolinska Institutet, Stockholm, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden, Authors' Affiliations: 1School of Population Health, Centre for Molecular Environmental, Genetic and Analytic Epidemiology, 2Department of Pathology, University of Melbourne; 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; 4Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles; 5Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 6University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany; 7Area de Epidemiologia Ambiental y Cáncer, Centro Nacional de Epidemiologia, Instituto de Salud Carlos III; 8Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiologia y Salud Pública CIBERESP); 9Human Genetics Group, Spanish National Cancer Research Centr; Authors' Affiliations: 1School of Population Health, Centre for Molecular Environmental, Genetic and Analytic Epidemiology, 2Department of Pathology, University of Melbourne; 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; 4Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles; 5Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 6University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany; 7Area de Epidemiologia Ambiental y Cáncer, Centro Nacional de Epidemiologia, Instituto de Salud Carlos III; 8Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiologia y Salud Pública CIBERESP); 9Human Genetics Group, Spanish National Cancer Research Centr Department of Human Genetics, Genome Institute of Singapore, Singapore, Singapore; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Södersjukhuset, Stockholm, Sweden Maren Weischer, Børge G. Nordestgaard, Henrik Flyger, and Stig E. Bojesen, University of Copenhagen, Copenhagen, Denmark; Paul Pharoah, Manjeet K. Bolla, Alison M. Dunning, Qin Wang, Mitul Shah, and Douglas F. Easton, University of Cambridge, Cambridge; Montserrat Garcia-Closas, Institute of Cancer Research, London; Angela Cox, Malcolm W.R. Reed, and Simon S. Cross, University of Sheffield, Sheffield, United Kingdom; Heli Nevanlinna, Taru A. Muranen, and Carl Blomqvist, University of Helsinki and... Department of Medical Epidemiology and Biostatistics, Karolinska Institute, PO Box 281, SE-171 77 Stockholm, Sweden. Per.Hall@mep.ki.se Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden Karolinska Institutet Authors' Affiliations: 1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research; 3Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, United Kingdom; 4Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health and 5Department of Pathology, The University of Melbourne; 6Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Research Division, Peter MacCallumCancer Center; 7Cancer Epidemiology Centre, Cancer Council Victoria; 8The Alfred Hospital, Melbourne, Victoria, Australia; Departments of 9Epidemiology and 10Molecular Pathology, The Netherlands Cancer Institute - The Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 11Warwick Medical School, Warwick University, Coventry, United Kingdom; 12Departm Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden; Department of Oncology Södersjukhuset Stockholm Sweden 1Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Solna, Sweden.; 3Department of Oncology, Södersjukhuset, Stockholm, Sweden. Marjanka K. Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, and Lizet van der Kolk, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital; Muriel A. Adank, Hanne Meijers, and Quinten Waisfisz, VU University Medical Center, Amsterdam; Antoinette Hollestelle, Mieke Schutte, Maartje Hooning, and Caroline Seynaeve, Erasmus MC Cancer Institute; Ans van den Ouweland, Erasmus University Medical Center, Rotterdam; Rob A.E.M. Tollenaar, Leiden University Medical Center,... Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden From the Department of Medical Epidemiology and Biostatistics, Stockholm Söder Hospital and Oncologic Center, Clintec, and Department of Oncology, Radiumhemmet, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; and the Department of Epidemiology, Harvard University, Boston, MA Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm; Department of Oncology Södersjukhuset Stockholm Jingmei Li, Genome Institute of Singapore, Singapore; Keith Humphreys, Louise Eriksson, Gustaf Edgren, Kamila Czene, and Per Hall, Karolinska Institutet, Stockholm, Sweden; and Gustaf Edgren, Harvard School of Public Health, Harvard University, Boston, MA. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, South General Hospital, Stockholm, Sweden Affiliations of authors: Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK (EMA, JT, PDPP); Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (EMA, NEC); Bavarian Breast Cancer Cases and Controls (BBCC), University Breast Center (PAF, MWB) and BBCC, Institute of Diagnostic Radiolo Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm Sweden Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Authors' Affiliations: 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Genome Institute of Singapore, 60 Biopolis Street, #02-01, Singapore 138672; Department of Oncology and Pathology, Radiumhemmet, Karolinska Institute and Hospital, S-17176 Stockholm, Sweden; and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden professor, överläkare, institutionen för medicinsk epidemiologi och biostatistik, Karolinska institutet; onkologkliniken, Södersjukhuset, Stockholm. The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the... Department of Oncology, Södersjukhuset, Stockholm, Sweden. From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet; Department of Surgery, South Hospital, Stockholm, Sweden; Department of Public Health, University of Helsinki; Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, Finland; The Danish Twin Registry, University of Southern Denmark, Odense, Denmark; Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London; and the Section of Epidemiology,... Department of Medical Epidemiology and Biostatistics, 9Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet; Departments of 5Department of Epidemiology, Karolinska Insitutet, Stockholm, Sweden Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska institutet, Stockholm. per.hall@ki.se Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, 171 65, Sweden; Södersjukhuset, Department of Oncology, Stockholm, 118 83, Sweden. 24Singapore and Swedish Breast Cancer Study: Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden (K.C. and P.H.) and Human Genetics, Genome Institute of Singapore, Singapore, Singapore (Y.L. and J.L.); 2Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 65, Sweden; Department of Oncology, Södersjukhuset, Stockholm 118 83, Sweden. Consultant Plastic and Reconstructive Surgeon, East of England Cleft Lip and Palate Network, Cambridge University Hospitals NHS Foundation Trust, Cambridge, U.K. 3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; 4Department of Oncology, Södersjukhuset, Stockholm, Sweden. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 77, Sweden. Medical Epidemiology and Biostatistics Karolinska Institute Sweden Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm SE‐17177 Sweden Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain Authors' Affiliations: 1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Tr Affiliations of authors: Department of Medical Epidemiology and Biostatistics (WH, FF, HO, PH, KC), Clinical Epidemiology Unit (KES), and Department of Oncology-Pathology (SM), Karolinska Institutet, Stockholm, Sweden; Department of Oncology, South General Hospital, Stockholm, Sweden (SM, PH). Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet; Department of Hospital Physics, Radiumhemmet, and Department of Medicine, Clinical Epidemiology Unit, Karolinska University Hospital; Department of Medical Radiation Physics, Stockholm University, Stockholm, Sweden; and Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC. Department of Medical Epidemiology and Biostatistics (L.Y., A.N.I., P.H., S.L.), 17177, Stockholm, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. From the Princess Margaret Hospital, University Health Network, and the Department of Radiation Oncology, University of Toronto, Canada; Division of Cancer Epidemiology and Genetics and the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; The University of Iowa, Iowa City, IA; Danish Cancer Society, Copenhagen, Denmark; Karolinska Institute, Stockholm, Sweden; The Norwegian Cancer Registry; Norwegian Radium... Lindsay M. Morton, Graça M. Dores, Rochelle E. Curtis, Ethel S. Gilbert, Ruth A. Kleinerman, and Joseph F. Fraumeni Jr, National Cancer Institute, Bethesda, MD; Graça M. Dores, Department of Veterans Affairs Medical Center, Oklahoma City, OK; Charles F. Lynch, University of Iowa, Iowa City, IA; Marilyn Stovall, Susan A. Smith, and Rita E. Weathers, University of Texas MD Anderson Cancer Center, Houston, TX; Per Hall and Magnus Kaijser, Karolinska Institute, Stockholm, Sweden; David C. Hodgson and Eric J.... Carolyn Taylor, Paul McGale, David Cutter, Frances K. Duane, Zhe Wang, and Sarah C. Darby, Nuffield Department of Population Health, University of Oxford; Kazem Rahimi, George Institute for Global Health, University of Oxford, Oxford, United Kingdom; Dorthe Brønnum, North Denmark Regional Hospital, Hjoerring; Maj-Britt Jensen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen; Ebbe Lorenzen and Marianne Ewertz, Odense University Hospital, Odense, Denmark; Candace Correa, Community Cancer... 73Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, 35Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm Sweden; Department of Oncology South General Hospital Stockholm Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Karolinska institutet, Stockholm. Per.Hall@ki.se Johanna Holm, Keith Humphreys, Jingmei Li, Alexander Ploner, Abbas Cheddad, Mikael Eriksson, Per Hall, and Kamila Czene, Karolinska Institutet; Sven Törnberg, Stockholm-Gotland Regional Cancer Centre, Stockholm, Sweden; and Jingmei Li, Genome Institute of Singapore, Singapore, Singapore. |
Incoming Links
Total number of triples: 571.